Nuwellis (NUWE) Competitors $5.64 +0.14 (+2.55%) Closing price 04:00 PM EasternExtended Trading$5.50 -0.14 (-2.48%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUWE vs. AVGR, BBLG, DYNT, BIOL, TTOO, IONM, HSDT, SDCCQ, GMVDF, and VRAYQShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Avinger (AVGR), Bone Biologics (BBLG), Dynatronics (DYNT), BIOLASE (BIOL), T2 Biosystems (TTOO), Assure (IONM), Helius Medical Technologies (HSDT), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), and ViewRay (VRAYQ). These companies are all part of the "medical equipment" industry. Nuwellis vs. Its Competitors Avinger Bone Biologics Dynatronics BIOLASE T2 Biosystems Assure Helius Medical Technologies SmileDirectClub G Medical Innovations ViewRay Nuwellis (NASDAQ:NUWE) and Avinger (NASDAQ:AVGR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk. Which has higher earnings and valuation, NUWE or AVGR? Nuwellis has higher revenue and earnings than Avinger. Avinger is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuwellis$8.74M0.06-$11.16M-$766.39-0.01Avinger$7.65M0.21-$18.32M-$11.06-0.04 Does the media refer more to NUWE or AVGR? In the previous week, Nuwellis had 9 more articles in the media than Avinger. MarketBeat recorded 9 mentions for Nuwellis and 0 mentions for Avinger. Avinger's average media sentiment score of 0.00 beat Nuwellis' score of -0.01 indicating that Avinger is being referred to more favorably in the news media. Company Overall Sentiment Nuwellis Neutral Avinger Neutral Do analysts rate NUWE or AVGR? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nuwellis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Avinger 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals believe in NUWE or AVGR? 3.1% of Nuwellis shares are owned by institutional investors. Comparatively, 18.3% of Avinger shares are owned by institutional investors. 20.1% of Nuwellis shares are owned by insiders. Comparatively, 42.8% of Avinger shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is NUWE or AVGR more profitable? Avinger has a net margin of 0.00% compared to Nuwellis' net margin of -112.09%. Avinger's return on equity of 0.00% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Nuwellis-112.09% -655.31% -141.83% Avinger N/A N/A N/A SummaryAvinger beats Nuwellis on 8 of the 14 factors compared between the two stocks. Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUWE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUWE vs. The Competition Export to ExcelMetricNuwellisMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$580K$7.07B$5.62B$9.84BDividend YieldN/A1.30%4.61%4.07%P/E Ratio-0.0125.4830.2925.74Price / Sales0.0673.48463.41115.83Price / CashN/A21.9738.2159.48Price / Book0.095.388.826.15Net Income-$11.16M$176.29M$3.25B$265.06M7 Day Performance7.02%3.76%4.05%2.80%1 Month Performance-27.78%-0.66%4.32%1.68%1 Year Performance-94.08%12.98%36.25%29.59% Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUWENuwellis1.4197 of 5 stars$5.64+2.5%N/A-93.9%$580K$8.74M-0.0170News CoverageEarnings ReportShort Interest ↓AVGRAvingerN/A$0.47flatN/AN/A$1.57M$7.65M-0.0470BBLGBone Biologics1.6709 of 5 stars$2.69-1.8%N/A-74.2%$1.48MN/A0.002Earnings ReportShort Interest ↓DYNTDynatronicsN/A$0.08-0.5%N/A-40.4%$1.06M$33.60M-0.10200Gap UpBIOLBIOLASE0.92 of 5 starsN/A$1.20+∞N/A$581K$48.83M0.00160TTOOT2 BiosystemsN/A$0.02-80.6%N/A-99.7%$326K$7.68M0.00180Short Interest ↓Gap DownIONMAssureN/A$0.05flatN/A-84.4%$150K$149K0.00130HSDTHelius Medical Technologies0.4936 of 5 stars$5.90-1.7%N/A-98.9%$59K$520K0.0030Negative NewsEarnings ReportShort Interest ↑SDCCQSmileDirectClubN/AN/AN/AN/A$40K$470.74M0.002,700GMVDFG Medical InnovationsN/A$0.00flatN/AN/A$26K$4.42M0.0072VRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300High Trading Volume Related Companies and Tools Related Companies AVGR Alternatives BBLG Alternatives DYNT Alternatives BIOL Alternatives TTOO Alternatives IONM Alternatives HSDT Alternatives SDCCQ Alternatives GMVDF Alternatives VRAYQ Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUWE) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access